Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 8 of 8 for “"Brain Cancer Therapy"”.

  1. High precision tools for intraoperative brain cancer therapy

    Glioblastoma remains to be the most aggressive brain malignancy to affect adults. The disease has a median survival of only 15 months, owing to tumour recurrence within 2 cm of the primary tumour site. Despite the poor prognosis, standard treatment still relies heavily on surgical resection of the …

    edinburgh Repository record for High precision tools for intraoperative brain cancer therapy (opens in a new tab)

  2. Addressing a Major Hurdle for Brain Cancer Therapy: Widespread Therapeutic Delivery

    … is an attractive method to bypass the blood-brain barrier and facilitate widespread therapeutic distribution within brain parenchyma by creating a continuous pressure-driven bulk flow. In this work I demonstrate that local infusion of nanoparticle (NP)-based delivery systems designed to …

    jhu Repository record for Addressing a Major Hurdle for Brain Cancer Therapy: Widespread Therapeutic Delivery (opens in a new tab)

  3. Discovery and Application of Neoepitopes in an Oncolytic Rhabdovirus Vaccine Approach to Treat Glioblastoma Multiforme

    … multiforme is the most common and lethal primary brain tumour in adults. Its aggressive and invasive phenotype makes it resistant to current standards of care, with a patient median survival following treatment of only 14 months. Potent and safe therapeutics are necessary to improve patient …

    ottawa-retro Repository record for Discovery and Application of Neoepitopes in an Oncolytic Rhabdovirus Vaccine Approach to Treat Glioblastoma Multiforme (opens in a new tab)

  4. Photodynamische Therapie mit Tetrahydroporphyrin-Tetratosylat (THPTS) und ihre Kombination mit ionisierender Strahlung in humanen Glioblastomzellen

    So far, glioblastomas cannot be cured by standard therapy and have an extremely poor median survival of about 15 months. The photodynamic therapy (PDT) with next generation photosensitizers, reaching a higher therapeutic depth, might offer a new, adjuvant treatment strategy in brain cancer therapy. …

    qucosa-diss

  5. Inhibition of telomerase activity and cell growth by natural plant products in human brain cancer cells

    According to Global Cancer Statistics 2002, brain cancer, one of the most challenging cancers to treat, with its high mortality rate, accounted for 189,000 new cases and 142,000 deaths worldwide annually. Cancer Statistics 2005 reported 18,500 new cases and 12,760 deaths in the United States. …

    nus Repository record for Inhibition of telomerase activity and cell growth by natural plant products in human brain cancer cells (opens in a new tab) Download file for Inhibition of telomerase activity and cell growth by natural plant products in human brain cancer cells (opens in a new tab)

  6. Irreversible Electroporation for the Treatment of Aggressive High-Grade Glioma

    … High-grade variants of this type of brain cancer are generally considered incurable with singular or multimodal therapies. Many patients with GBM die within one year of diagnosis, and the 5-year survival rate in people is approximately 10%. Despite extensive research in diagnostic and …

    vt Repository record for Irreversible Electroporation for the Treatment of Aggressive High-Grade Glioma (opens in a new tab)

  7. Investigating the Applications of Electroporation Therapy for Targeted Treatment of Glioblastoma Multiforme Based on Malignant Properties of Cells

    … (GBM) is the most common and lethal primary brain cancer with an average survival time of 15 months. GBM is considered incurable with even the most aggressive multimodal therapies and is characterized by near universal recurrence. Irreversible electroporation (IRE) is a cellular ablation …

    vt Repository record for Investigating the Applications of Electroporation Therapy for Targeted Treatment of Glioblastoma Multiforme Based on Malignant Properties of Cells (opens in a new tab)